Galderma Investigational Site 8903

Calgary, Alberta T2J 7E1

0 studies enrolling now · 2 studies all time

What they study most

Moderate-to-Severe Atopic Dermatitis

Studies at this site

• Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis — Running, not enrolling
• Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis — Completed